IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC, 2nd Aquisition by CVC in 2 Months

In one of the largest corporate carvings in the modern specialty ingredients sector, International Flavors & Fragrances Inc. (IFF) has completed the sale of its specialized ingredients division to global private equity powerhouse CVC Capital Partners in a transaction valued at USD 4.3 billion. 

This is the 2nd acquisition by CVC Capital Partners in as many months as it previously scooped up part of business from dsm-firmenich in month of May 2026.

The deal represents a major turning point for the global food, beverage, and pharmaceutical supply chains. For IFF, the divestiture is a calculated step to reduce debt and sharpen its focus on core bioscience, scent, and taste technologies. Meanwhile, CVC Capital Partners gains a high-margin, asset-rich business, which it plans to scale into an independent, global ingredients champion.

Transaction Mechanics & Valuation Architecture

The USD 4.3 billion enterprise value represents a highly robust valuation multiple, highlighting the steady demand for specialized, functional food and pharma ingredients.

Financial Highlights

• Cash Proceeds: The transaction is an all-cash deal, providing IFF with approximately USD 4.3 billion in gross proceeds. After accounting for taxes and transaction fees, the net cash influx will immediately be deployed to optimize IFF’s balance sheet.

• Deleveraging Mandate: A significant portion of the net proceeds will be used to pay down IFF’s outstanding debt. The corporate treasury team expects this move to reduce the company’s net-debt-to-EBITDA leverage ratio toward a healthier < 3.0x threshold, helping to protect its investment-grade credit rating.

• Operating Footprint Transfer: The divestiture includes a comprehensive global infrastructure transfer, spanning several specialized production facilities, dedicated R&D laboratories, and an extensive intellectual property portfolio covering texturizers, binders, stabilizers, and specialized excipients.

Future Outlook: IFF’s Leaner, High-Margin Focus

With this major division off its balance sheet, IFF transitions into a leaner, more agile enterprise. The move marks the end of a multi-year consolidation phase following its massive merger with DuPont’s Nutrition & Biosciences business, shifting focus away from capital-intensive commodity segments toward high-margin, IP-protected biological innovations.

Moving forward, IFF is concentrating its capital expenditure on three primary pillars:

1. Advanced Scent Technologies: Expanding its footprint in consumer fragrance markets using digital micro-encapsulation and sustainable biotechnology.

2. Next-Generation Taste Innovation: Developing natural, clean-label flavor modulators aimed at the plant-based protein, functional beverage, and health sectors.

3. High-Yield Industrial Bioscience: Investing in enzymatic and microbial synthesis to deliver eco-friendly, high-performance ingredients to the global market.

CVC’s Vision: Building an Independent Ingredients Powerhouse

For CVC Capital Partners, the USD 4.3 billion acquisition provides a strong foundation for a dedicated, standalone ingredients platform. Private equity investment in this sector is driven by steady, non-cyclical consumer demand, as food and pharma manufacturers rely heavily on these functional ingredients regardless of broader macroeconomic fluctuations.

CVC’s strategy for the newly acquired business centers on operational agility and strategic market expansion:

• Supply Chain Optimization: Decoupling the division from IFF’s legacy corporate framework allows the new entity to optimize its procurement, logistics, and production schedules, leading to faster response times for global food and pharma manufacturers.

• Targeted M&A Rollups: CVC plans to use the new platform to acquire mid-tier, specialized ingredient developers across Europe and Asia, particularly targeting clean-label texturizers and plant-based hydrocolloids to expand its product portfolio.

• Accelerating Product Development: By increasing R&D funding for high-demand areas like sugar reduction, sodium reduction, and clean-label preservation, CVC aims to position the business as a premier innovation partner for global consumer packaged goods (CPG) brands.

Long-Term Industry Impact

This multi-billion-dollar transaction reflects a broader trend of portfolio optimization across the global chemical and life sciences sectors. As major players face pressure to streamline operations, the industry is shifting away from massive conglomerates toward highly specialized, agile companies.

As IFF strengthens its balance sheet to focus on bio-driven taste and scent technologies, and CVC builds out a nimble, independent ingredients giant, the deal looks set to foster increased innovation and competition across the global food and pharmaceutical supply chains.